-
Mashup Score: 7
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Dilraj S. Grewal, MD, FASRS, provides an update on the progress of therapies for noninfectious uveitis. While some therapies failed trials, others demonstrated promising results, including dazdotuftide (Tarsier Pharma), which reduced inflammation in patients with uveitis without raising IOP in a phase 3
Source: www.healio.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 7
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Dilraj S. Grewal, MD, FASRS, provides an update on the progress of therapies for noninfectious uveitis. While some therapies failed trials, others demonstrated promising results, including dazdotuftide (Tarsier Pharma), which reduced inflammation in patients with uveitis without raising IOP in a phase 3
Source: www.healio.comCategories: General Medicine News, OphthalmologyTweet-
#RetinaWorldCongress coverage from @GoHealio kicks off with an update on noninfectious #uveitis! Dr. Dilraj Grewal shares info on “exciting” new therapies in the pipeline👇 #OcularSurgeryNews @RetinaWCongress https://t.co/2lScWFJrnR https://t.co/sdsnydu8NM
-
#RetinaWorldCongress coverage from @GoHealio kicks off with an update on noninfectious #uveitis! Dr. Dilraj Grewal shares info on “exciting” new therapies in the pipeline👇 #OcularSurgeryNews @RetinaWCongress https://t.co/2lScWFJrnR https://t.co/sdsnydu8NM